Notice on discontinuation in the supply chain with Virolex 30 mg/1 g eye ointment (acyclovir)
The marketing authorisation holder for Virolex 30 mg/1 g eye ointment (acyclovir), Krka – farma d.o.o., has notified the Agency for Medicinal Products and Medical Devices of a permanent discontinuation in the supply chain of the Croatian market with this medicine. The decision has been taken due to commercial reasons and in not related to quality, safety or efficacy of the medicine.
Virolex 30 mg/1 g eye ointment is indicated for the treatment of herpes keratitis. There is no other authorised medicinal product on the Croatian market of the same pharmaceutical form containing this active substance that is authorised for this indication. Therefore, HALMED will upon wholesaler’s request, for the treatment of patients in hospital settings or for patient named treatments, approve the enter of a medicinal product not having a marketing authorisation in Croatia.